This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This election year, Capitol Hill buzzed with discussions about cannabis scheduling, hemp regulations, and the FDA’s evolving role in regulating cannabinoids. As we head toward the 2024 election, it’s clear that cannabis policies will shift in the next Congress, impacting the lives of patients and families across the nation.
Project CBD , a California-based educational non-profit, has published an in-depth primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. See bottom of this article for downloads. The 33-page report, summarized below, is available for free download at the bottom of the page.
Project CBD , a California-based educational non-profit, has published an in-depth primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. The 33-page report, summarized below, is available for free download at the bottom of the page.
The studys findings indicate that many so-called hemp products are infused with synthetic psychoactive cannabinoids, which can actually make users feel loopier than natural Delta-9 THC. Californias Assembly Bill 45, passed in 2021, explicitly states: Industrial hemp does not include cannabinoids produced through chemical synthesis.
Project CBD , a California-based educational non-profit, has published an in-depth primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. See bottom of this article for downloads. The 33-page report, summarized below, is available for free download at the bottom of the page.
The mission of the United Cannabis Business Association is to establish a comprehensive, statewide cannabinoidpolicy. It is in that same spirit that UCBA has spent the last three years advocating for responsible consumable hemp policy. Such a policy includes equal safety testing requirements to protect public health.
My educational investment in the industry has offered me, through my focus on regulation and policy, the opportunity to collaborate as an advisor with several advocacy and education intermediary organizations focused on federal policy change for medical cannabis patients and a nascent, struggling industry that is supporting them.
You have been seeing and hearing about it everywhere lately — but what are novel cannabinoids like Delta-8, and what does the increasing proliferation of products containing them mean for state and federal policymakers? We apply our entirely subjective bong score to each event. 1 Don’t Bother Unless You Need A Well Deserved Sleep.
In Indianapolis on January 29, a quiet, eager audience of nurses give their rapt attention to Jason Straw as he takes center stage at the 2020 ISNA Policy Conference. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. ISNA 2020 POLICY CONFERENCE AGENDA, Jason Straw- Cannabis Policy. PURPOSE : .
Cannabis companies that hire drivers to work for them—such as delivery services and goods transporters—are being advised by the Centers for Disease Control and Prevention (CDC) to establish certain policies that can mitigate the risk of impaired driving, all the while ensuring that companies remain in alignment with state legalization laws.
Synthetic cannabinoids, free of THC but capable of creating the same (if not more intense) psychedelic effects as THC, are thus not subject to the same ban. In fact, earlier this year Japan’s government banned the trendy synthetic cannabinoid HHC. What do you think of Japan’s growing synthetic cannabinoid market? The post U.S.
As states crack down on delta-8 THC production and sales, the market remains curious: Where does this cannabinoid fit into the broader ecosystem of cannabis and hemp? You will learn the context behind this cannabinoid and the opportunities that accompany emerging consumer trends like this one. Are there any market opportunities here?
Such products will generate sales of £690 million ($856 million, 811 million euros) in 2021, according to the Association for the Cannabinoid Industry (ACI). Britain has experienced a “quiet cannabis revolution” that has transformed it into “the world’s second largest consumer cannabinoids market”, ACI said.
Additional clinical trial data indicates that cannabinoids possess synergistic activity with opioids, which “may allow for opioid treatment at lower doses with fewer [patient] side effects.”
Project CBD: Your presentation with Allyn Howlett at the International Cannabinoid Research Society conference in Toronto (June 2023) discussed the chemical conversion of CBD into Δ8-THC (delta-8 THC) and “numerous additional THC isomers. At issue are potent, intoxicating cannabinoids other than cannabis-derived Δ9-THC.
Marijuana Moment, a marijuana policy blog, first reported the update. Cannabinoid oil, or CBD, can be extracted and processed from the hemp plant to be used for medicinal purposes. Some local airports said the rule change would not change the way they operate, while others were not aware any policies were altered at all.
But when it comes to law and policy, what are the definitive terms we should be using when talking about cannabis? Published in Drug Science, Policy and Law , the study is the first of its kind to examine the different nomenclature systems used for cannabis in the worlds of law and academia. Not always, according to a new study.
Last August, the agency announced that it would once again be reassessing and amending its policies. percent THC), or who wish to extract cannabinoids from plants that meet the federal definition of hemp, are not subject to the DEA’s licensing requirements.
Now, in 2015 — like in many other states throughout the country — we saw some fresh faces in the marijuana policy conversation. And instead of having the government arbitrarily select [qualifying] conditions, it would probably be a better public policy approach to let doctors decide. They managed to hold on to that.
Neil Mahapatra is a co-founder of the Oxford Cannabinoid Technologies (OCT) which floated on the LSE in the May this year, he is also founder of UK venture capital business Kingsley Capital Partners (KCP). Oxford Cannabinoid Technologies’ Shares Fall A Further 20% As Chairman Stands Down Following Market Rule Breach.
Introduction The endocannabinoid system (ECS) is a group of cannabinoid receptors located throughout the body, but particularly in the brain and central nervous system, that interact with cannabis compounds. There are two major cannabinoid receptors: CB1 and CB2. There are two major cannabinoid receptors: CB1 and CB2.
Certain conditions require more cannabinoids than others. The reality is that cannabinoids have very individualized effects on human beings. The biggest reason price is such an issue is because there are no regular health insurance offsets for cannabis products. That means every sale is cash, directly out of consumers’ pockets.
Although many of these athletes did not consume cannabis prior to games, fights, and other competitions but rather in their own free times, it did not matter as cannabis has been listed in many of the leagues’ anti-doping and drug policies since their inception. A Statement Regarding the Changes. Athletes That Have Come Forward.
percent THC) and products containing cannabinoids derived from hemp from the federal Controlled Substances Act. ” In March, outgoing FDA Commissioner Scott Gottlieb suggested that it may take “years” for the agency to establish rules and regulations governing the marketing of hemp-derived cannabinoid products. .”
And while many of the regulatory rules have been crafted thoughtfully, existing cannabis policy gaps have contributed to concerning market behavior. Recently, the cannabis marketplace has seen some interesting developments in the way of synthetic cannabinoids. The Emergence of Synthetic Cannabinoids: Delta-8.
The board will share its position with state leaders, who would be responsible for making legislative changes to Utah’s delta-8 policy. The Utah Cannabinoid Product Board has heard from researchers and reviewed literature on delta-8, and board members voted unanimously Feb. Hemp Grower. ” [link].
The endocannabinoid system consists of cannabinoid receptors all over the body. Medical marijuana and cannabinoids can be used to treat a patient’s physical and psychological health, alleviating the debilitating symptoms of PTSD. Cannabis offers significant therapeutic benefits for a wide range of medical conditions.
A cardiologist with no public comments on cannabinoid therapies, Dr. Robert Califf, has been nominated to take over as commissioner of the U.S. Califf has said nothing publicly about cannabinoids such as CBD. Hemp Today reports. Food and Drug Administration. More at [link].
The Washington State Liquor and Cannabis Board (WSLCB) has been working on developing policies related to the regulation of cannabinoids, and is in search of members for its first Cannabinoid Science Work Group.
Director of Policy (Deputy Director, NS) #10901. The Policy Director will also oversee the development and implementation of the Office’s public health educational campaign as well as the monitoring, surveillance, and reporting on key metrics related to the impacts of cannabis legalization. Range From $112155 to $141538 Annually.
New York marijuana regulators on Wednesday approved rules for the state’s cannabinoid hemp program, notably clarifying that flower from the crop can be sold but delta-8 THC products are currently prohibited from being marketed. That policy was the subject of their previous meeting late last month.
The effects of cannabis are caused by cannabinoids, which are chemical compounds found in the resin glands on the leaves and buds of female marijuana plants. Cannabinoids can help with inflammation and pain relief in various ways. Cannabis contains two types of cannabinoids: phytocannabinoids and endocannabinoids.
Green Light Law Group: OLCC Finalizes New Rules on Delta-8 THC and other Artificially Derived Cannabinoids. The Oregon Liquor Control Commission (OLCC) recently finalized new administrative rules on Delta-8 THC and other artificially derived cannabinoids as … Read More. Per the CDC, … Read More.
All are cost-prohibitive and contain only chemical copies of cannabinoids. Epiodiolex is not currently available, nor are any plants or plant-derived cannabinoids. Since this decision was made, only a few medications with synthetic cannabinoids have been made available to the public. Possible penalties for weed in Ukraine.
CBD and other cannabinoids are fast becoming (if not already) household names. First by the European Union, whose Common Agricultural Policy caps THC concentrations at 0.2 THC as the “arbitrary threshold at which cannabinoid content is used to distinguish strains of hemp from marijuana.”. Hemp is legal.
The Oregon Liquor Control Commission (OLCC) recently finalized new administrative rules on Delta-8 THC and other artificially derived cannabinoids as directed by HB 3000 (2021). Delta-8 THC and other Artificially Derived Cannabinoids. Artificially Derived Cannabinoids Allowed in SOME Situations.
because that person does or does not smoke, vape, aerosolize or otherwise use cannabis items, and an employee shall not be subject to any adverse action by an employer solely due to the presence of cannabinoid metabolites in the employee’s bodily fluid” is now effective. take any adverse action against any employee .
Especially for Texas… I’ve started doing podcasts for the American Bar Association Cannabis Law & Policy Committee. Friends, I hope everyone had an amazing New Year. It is going to be a great one! Here are a couple: Litigating the Controlled Substances and […].
All cannabinoids have potential to be therapeutic in the treatment of MG. There are over 140 cannabinoids in the cannabis plant. There is a third cannabinoid which also has shown success in the treatment of MG. There is a third cannabinoid which also has shown success in the treatment of MG.
Through community outreach, social media campaigns, educational seminars, and mental health screenings, the month seeks to empower individuals to seek help when needed, cultivate supportive environments, and advocate for policies that promote mental health equity and access to care. Featured image by Dan Meyers on Unsplash.
An Oregon legislative task force established pursuant to HB 3000 (2021) and SB 1564 (2022) is developing policy proposals for 2023 relating to intoxicating cannabinoid products, illegal cannabis production, and water rights issues. Cannabinoid Subcommittee. Source: [link].
A new commission for the United Kingdom (UK), the Hodges Review of UK Public Policy and Regulatory Stewardship of the Legal Cannabis Industry, will analyze its current legal cannabis industry and make recommendations on how to best maximize its growth, consumer satisfaction, and competitive potential on a global scale.
Although the UK recently severed its ties with the European Union, the FSA has opted to align its policy with that of the European Food Safety Authority (“ EFSA ”). The EFSA guidance on cannabinoids strongly echoes the U.S.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content